Catalyst
Slingshot members are tracking this event:
Merrimack (MACK) Presents Final Phase 3 NAPOLI-1 Data Evaluating ONIVYDE in Pancreatic Cancer
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| MACK |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 11, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3, Napoli-1, Onivyde, Metastatic Pancreatic Ductal Adenocarcinoma, Following Gemcitabine-based Therapy, Pancreatic Cancer, European Society For Medical Oncology
